1/11
Proverbs 16:3
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
c. Prostate-specific antigen (PSA)
[TUMOR MARKER]
Prostate
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
a. CA 125
[TUMOR MARKER]
Ovarian
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
d. CA 19-9
[TUMOR MARKER]
Pancreatic
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
● CA 15-3
● Human epidermal growth factor receptor 2 (HER2)
[TUMOR MARKER]
(multiple answer)
Breast
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
b. Human chorionic gonadotropin (HCG)
[TUMOR MARKER]
Trophoblastic
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
g. Alpha-fetoprotein (AFP)
[TUMOR MARKER]
Hepatocellular
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
h. Pepsinogen
[TUMOR MARKER]
Gastric
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
● Prostate-specific antigen (PSA)
● CA 125
● Human chorionic gonadotropin (HCG)
[CLINICAL APPLICATION]
(multiple answer)
● Primary Screening
● Determining Prognosis
● Monitoring Therapy
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
● CA 19-9
● CA 15-3
[CLINICAL APPLICATION]
(multiple answer)
Monitoring therapy
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
e. Human epidermal growth factor receptor 2 (HER 2)
[CLINICAL APPLICATION]
Predicting response to therapy
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
g. Alpha-fetoprotein (AFP)
[CLINICAL APPLICATION]
● Primary Screening
● Monitoring Therapy
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen
h. Pepsinogen
[CLINICAL APPLICATION]
Primary screening
a. CA 125
b. Human chorionic gonadotropin (HCG)
c. Prostate-specific antigen (PSA)
d. CA 19-9
e. Human epidermal growth factor receptor 2 (HER 2)
f. CA 15-3
g. Alpha-fetoprotein (AFP)
h. Pepsinogen